Relmada Therapeutics (RLMD) Return on Capital Employed Growth (5y) (2019 - 2026)
Relmada Therapeutics (RLMD) Return on Capital Employed Growth (5y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Relmada Therapeutics |
581.07 Mn |
581.07 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
3,478.00 |
| Dec 31, 2025 |
-6,743.00 |
| Sep 30, 2025 |
-41,363.00 |
| Jun 30, 2025 |
-33,781.00 |
| Mar 31, 2025 |
-22,816.00 |
| Dec 31, 2024 |
-17,658.00 |
| Jun 30, 2024 |
20,053.00 |
| Mar 31, 2024 |
123,104.00 |
| Dec 31, 2023 |
164,329.00 |
| Sep 30, 2023 |
-26,194.00 |
| Mar 31, 2023 |
442,275.00 |
| Dec 31, 2022 |
32,584.00 |
| Sep 30, 2022 |
78,493.00 |
| Jun 30, 2022 |
25,981.00 |
| Mar 31, 2022 |
14,743.00 |
| Dec 31, 2021 |
7,056.00 |
| Sep 30, 2021 |
5,586.00 |
| Jun 30, 2021 |
9,929.00 |
| Mar 31, 2021 |
6,826.00 |
| Dec 31, 2020 |
8,484.00 |
